Marketo is not configured. Form in test mode, no data will be sent.

The purpose of the study was to characterize and encapsulate within 8 weeks a lipid based formulation in a Licaps® Drug Delivery System (Licaps® DDS) intended for a clinical trial to obtain Proof-of-Concept for an innovative treatment of gastro-intestinal diseases developed by Synergy Pharmaceuticals.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.